Osteoporoz: Tanı, Tedavi ve Fizyoterapi Yaklaşımları

Yazarlar

Özet

-

Referanslar

Aksoy, T., Demir, S., & Güneş, F. (2022). Vitamin D deficiency and osteoporosis prevalence in Turkish adults. Turkish Journal of Endocrinology, 29(4), 201–209.

Clarke, B. L. (2020). Osteoporosis: Pathophysiology and mechanisms. Bone, 138, 115–144.

Compston, J. (2022). Bone health and osteoporosis: Global burden and future perspectives. Nature Reviews Endocrinology, 18(4), 209–220.

Cummings, S. R., & Melton, L. J. (2002). Epidemiology and outcomes of osteoporotic fractures. New England Journal of Medicine, 347(12), 955–964.

Eastell, R., Rosen, C. J., & Black, D. M. (2019). Advances in the pathogenesis and management of osteoporosis. The Lancet, 393(10169), 364–376.

Erdoğan, M., & Akın, F. (2021). Osteoporosis prevalence and risk factors in rural Turkish women. Journal of Geriatric Medicine, 14(2), 87–94.

Hernlund, E., Svedbom, A., & Ivergård, M. (2019). Osteoporosis in the European Union: Medical management, epidemiology, and economic burden. Archives of Osteoporosis, 14(59), 1–15.

International Osteoporosis Foundation (IOF). (2024). Global Report on Osteoporosis 2024. Geneva: IOF Publications.

Kanis, J. A. (2023). Diagnosis of osteoporosis and assessment of fracture risk. Osteoporosis International, 34(1), 15–28.

Khosla, S. (2022). Sex steroid regulation of bone metabolism in men and women. Endocrine Reviews, 43(3), 295–325.

Papapoulos, S. E. (2022). Consequences and costs of osteoporotic fractures. Osteoporosis International, 33(2), 183–195.

Riggs, B. L., & Melton, L. J. (1986). Involutional osteoporosis. New England Journal of Medicine, 314(26), 1676–1686.

Sinaki, M. (2012). Exercise for patients with osteoporosis: Management of vertebral compression fractures and fall prevention. Mayo Clinic Proceedings, 87(8), 872–880.

Türkiye Osteoporoz Derneği (TOS). (2024). Ulusal Osteoporoz Rehberi 2024. Ankara: TOS Yayınları.

World Health Organization (WHO). (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, 843, Geneva.

World Health Organization (WHO). (2021). Healthy ageing and prevention of osteoporosis. Geneva: WHO.

Yıldız, N., Kaya, M., & Özkan, S. (2020). Postmenopausal osteoporosis prevalence and associated factors in Turkey. Turkish Journal of Physical Medicine and Rehabilitation, 66(3), 271–278.

Binkley, N., & Buehring, B. (2014). Sarcopenia and osteoporosis: Interrelationship and clinical implications. Journal of Bone and Mineral Research, 29(5), 995–1001.

Bonewald, L. F. (2019). The role of the osteocyte in bone and nonbone disease. Endocrinology and Metabolism Clinics of North America, 48(4), 745–758.

Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423(6937), 337–342.

Clarke, B. L. (2020). Osteoporosis: Pathophysiology and mechanisms. Bone, 138, 115–144.

Colaianni, G., Mongelli, T., & Grano, M. (2017). Myokines and bone: The role of muscle–bone crosstalk in aging and osteoporosis. Current Osteoporosis Reports, 15(6), 419–427.

Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P., & Varanasi, S. S. (2008). The cell biology of bone metabolism. Journal of Clinical Pathology, 61(5), 577–587.

Eriksen, E. F. (2010). Cellular mechanisms of bone remodeling. Reviews in Endocrine and Metabolic Disorders, 11(4), 219–227.

Frost, H. M. (2003). Bone’s mechanostat: A 2003 update. The Anatomical Record Part A, 275(2), 1081–1101.

Howe, T. E., Shea, B., Dawson, L. J., & Ross, C. (2019). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews, (7), CD000333.

Khosla, S. (2022). Pathogenesis of age-related bone loss and osteoporosis. Endocrine Reviews, 43(3), 295–325.

Manolagas, S. C. (2023). The biology of osteoporosis: New insights into old paradigms. Nature Reviews Endocrinology, 19(2), 85–98.

Mera, P., Laue, K., & Ferron, M. (2016). Osteocalcin signaling in energy metabolism and muscle function. Bone, 84, 117–123.

Raggatt, L. J., & Partridge, N. C. (2010). Cellular and molecular mechanisms of bone remodeling. Journal of Biological Chemistry, 285(33), 25103–25108.

Rizzoli, R. (2021). Nutritional aspects of bone health. Best Practice & Research Clinical Endocrinology & Metabolism, 35(5), 101562.

Robling, A. G., & Bonewald, L. F. (2020). The osteocyte: New insights. Annual Review of Physiology, 82, 485–506.

Seeman, E., & Delmas, P. D. (2006). Bone quality—The material and structural basis of bone strength and fragility. New England Journal of Medicine, 354(21), 2250–2261.

Sinaki, M. (2012). Exercise for patients with osteoporosis: Management of vertebral compression fractures and fall prevention. Mayo Clinic Proceedings, 87(8), 872–880.

Tagliaferri, C., Wittrant, Y., & Davicco, M. J. (2015). Muscle and bone, two interconnected tissues. Ageing Research Reviews, 21, 55–70.

Buckley L, et al. (2017). Arthritis Rheumatol., 69(8):1521–1537.

Compston J. (2018). Bone, 120:69–77.

Compston JE, McClung MR, Leslie WD. (2019). Lancet, 393(10169):364–376.

Eastell R, et al. (2022). Nat Rev Endocrinol., 18:337–352.

Eastell R, Szulc P. (2017). Nat Rev Endocrinol., 13(10):626–639.

Estrada K, et al. (2012). Nat Genet., 44(5):491–501.

Howe TE, et al. (2011). Cochrane Database Syst Rev., (7):CD000333.

Kanis JA, et al. (2023). Osteoporos Int., 34(2):245–276.

Kiel DP, et al. (2018). J Bone Miner Res., 33(9):1552–1560.

Kohrt WM, et al. (2004). Med Sci Sports Exerc., 36(11):1985–1996.

Law MR, Hackshaw AK. (1997). BMJ, 315(7112):841–846.

Maurel DB, et al. (2012). Alcohol Clin Exp Res., 36(4):607–615.

Manelli F, Giustina A. (2000). Endocr Rev., 21(3):245–260.

Morris JA, et al. (2019). Nat Genet., 51(2):258–266.

NIH Consensus Development Panel. (2020). JAMA, 323(9):910–920.

Ralston SH, Uitterlinden AG. (2010). Endocr Rev., 31(5):629–662.

Richards JB, et al. (2008). Nat Genet., 40(5):584–589.

Silverberg SJ. (2018). N Engl J Med., 379:1050–1059.

Tuchendler D, Bolanowski M. (2014). Endokrynol Pol., 65(2):134–142.

van Staa TP, et al. (2000). J Bone Miner Res., 15(6):993–1000.

Vestergaard P, et al. (2005). J Bone Miner Res., 20(3):480–486.

Ward KD, Klesges RC. (2001). Endocr Rev., 22(4):557–585.

Weinstein RS. (2011). Nat Rev Endocrinol., 7(9):551–561.

Weaver CM, et al. (2016). Osteoporos Int., 27(12):367–376.

Zheng HF, et al. (2015). Nat Genet., 47(4):389–397.

Appelman-Dijkstra NM, Papapoulos SE. (2018). Bone, 121:52–59.

Baron R, Kneissel M. (2013). Nat Med., 19(2):179–192.

Bonewald LF. (2011). J Bone Miner Res., 26(2):229–238.

Boyle WJ, Simonet WS, Lacey DL. (2003). Nature, 423(6937):337–342.

Compston JE, McClung MR, Leslie WD. (2019). Lancet, 393(10169):364–376.

Compston J. (2018). Bone, 120:69–77.

Eastell R, et al. (2022). Nat Rev Endocrinol., 18:337–352.

Harada S, Rodan GA. (2003). Nature, 423(6937):349–355.

Hofbauer LC, Brueck CC. (2010). Trends Endocrinol Metab., 21(8):537–544.

Khosla S. (2013). Endocr Rev., 34(5):658–690.

Khosla S, Monroe DG. (2018). Nat Rev Endocrinol., 14(9):513–527.

Lean JM, et al. (2016). J Pathol., 240(2):229–240.

Manolagas SC. (2010). Endocr Rev., 31(1):113–135.

Raggatt LJ, Partridge NC. (2010). J Biol Chem., 285(33):25103–25108.

Robling AG, Turner CH. (2009). Bone, 44(5):732–739.

Weinstein RS. (2011). Nat Rev Endocrinol., 7(9):551–561.

Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. New England Journal of Medicine. 2002; 348:1119–1126.

Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International. 2006;17(12):1726–1733.

Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376.

Sinaki M. Critical appraisal for exercise recommendations in osteopenia and osteoporosis. Annals of Rehabilitation Medicine. 2015;39(2):144–152.

Kanis JA, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International. 2020;31(1):1–44.

ISCD Official Positions. International Society for Clinical Densitometry (ISCD), 2023.

Lewiecki EM, et al. Osteoporosis diagnosis and management: clinical update. Mayo Clinic Proceedings. 2019;94(1):35–50.

Kanis JA, et al. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporosis International. 2008;19(4):385–397.

Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376.

Eastell R, et al. Bone turnover markers: current status and future directions. Osteoporosis International. 2018;29(1):11–24.

Lang TF, et al. Quantitative computed tomography of the spine and hip: assessment of bone mineral density. Journal of Clinical Densitometry. 2018;21(4):517–531.

Binks S, et al. MRI assessment of vertebral fractures in osteoporosis. European Radiology. 2017;27(2):895–907.

WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Report Series. 1994;843:1–129.

Black DM, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. NEJM. 1996;334: 1434–1441.

Cummings SR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. NEJM. 2009;361:756–765.

Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376.

Cumming RG, Klineberg RJ. Fall frequency and risk assessment in older people. J Am Geriatr Soc. 2002;50: 1220–1225.

Eastell R, et al. Management of osteoporosis in postmenopausal women. Lancet Diabetes Endocrinol. 2022;10: 264–277.

Holick MF. Vitamin D deficiency. N Engl J Med. 2017;357:266–281.

Howe TE, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011;7:CD000333.

Kanis JA, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2020;31:1–44.

Lewiecki EM, et al. Osteoporosis diagnosis and management: clinical update. Mayo Clin Proc. 2019;94:35–50.

Mangano KM, et al. Dietary protein and bone health. Nutrients. 2017;9:815.

McClung MR, et al. Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med. 2014;370:412–420.

Neer RM, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. NEJM. 2001;344:1434–1441.

Papapoulos SE. Bisphosphonates: mechanisms of action. Endocrine Reviews. 2008;29: 173–197.

Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.

Weaver CM, et al. Calcium and vitamin D in the management of osteoporosis. Osteoporos Int. 2016;27:367–376.

Sinaki M. Exercise for patients with osteoporosis: management of vertebral compression fractures and trunk muscle training. PM&R. 2012;4(11):882–888.

Howe TE, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011;CD000333.

Rizzoli R. Nutrition and bone health. Best Pract Res Clin Endocrinol Metab. 2021;35(5):101563.

Weaver CM, et al. Calcium, vitamin D, and protein in osteoporosis management. Osteoporosis International. 2020;31:1835–1850.

Saag KG, et al. Glucocorticoid-induced osteoporosis: update and review. New England Journal of Medicine. 2017;377: 1316–1325.

Papaioannou A, et al. 2019 Clinical practice guideline for the diagnosis and management of osteoporosis in Canada: summary. Osteoporosis International. 2019;30:3–44.

Sinaki M. Exercise for patients with osteoporosis: management of vertebral compression fractures and trunk muscle training. PM&R. 2012;4(11):882–888.

Türkiye Osteoporoz Derneği. Osteoporoz Tanı ve Tedavi Rehberi. 2024.

Kanis JA. Assessment of osteoporosis at the primary health-care level. WHO Technical Report. 2020.

Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376.

Papaioannou A, et al. 2019 Clinical practice guideline for the diagnosis and management of osteoporosis in Canada. Osteoporosis International. 2019;30:3–44.

Weaver CM, et al. Calcium, vitamin D, and protein in osteoporosis management. Osteoporosis International. 2020;31:1835–1850.

Rizzoli R. Nutrition and bone health. Best Pract Res Clin Endocrinol Metab. 2021;35(5):101563.

Sinaki M. Exercise for patients with osteoporosis: management of vertebral compression fractures and trunk muscle training. PM&R. 2012;4(11):882–888.

Howe TE, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011;CD000333.

Yayınlanan

10 Kasım 2025

Lisans

Lisans

Bu İnternet Sitesi içeriğinde yer alan tüm eserler (yazı, resim, görüntü, fotoğraf, video, müzik vb.) Akademisyen Kitabevine ait olup, 5846 sayılı Fikir ve Sanat Eserleri Kanunu ve 5237 sayılı Türk Ceca Kanunu kapsamında korunmaktadır. Bu hakları ihlal eden kişiler, 5846 sayılı Fikir ve Sanat eserleri Kanunu ve 5237 sayılı Türk Ceza Kanununda yer alan hukuki ve cezai yaptırımlara tabi olurlar. Yayınevi ilgili yasal yollara başvurma hakkına sahiptir.

Mevcut yayın biçimiyle ilgili ayrıntılar: PDF

PDF

ISBN-13 (15)

978-625-375-736-6

Publication date (01)

2025

Fiziksel Boyutlar